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Abstract
Objective: The purpose of this study was to identify associations between maternal and fetal genetic variants in candidate
genes and spontaneous preterm birth (PTB) in a Norwegian population and to determine the effect size of those
associations that corroborate a previous study of PTB.
Methods: DNA from 434 mother-baby dyads (214 cases and 220 controls) collected from the Norwegian Mother and Child
Cohort (MoBa) was examined for association between 1,430 single nucleotide polymorphisms in 143 genes and PTB. These
results were compared to a previous study on European Americans (EA) from Centennial Women’s Hospital in Nashville, TN,
USA. Odds ratios for SNPs that corroborated the Cenntennial study were determined on the combined MoBa and
Centennial studies.
Results: In maternal samples the strongest results that corroborated the Centennial study were in the prostaglandin E
receptor 3 gene (PTGER3; rs977214) (combined genotype p=3610
24). The best model for rs977214 was the AG/GG
genotypes relative to the AA genotype and resulted in an OR of 0.55 (95% CI=0.37–0.82, p=0.003), indicating a protective
effect. In fetal samples the most significant association in the combined data was rs854552 in the paraoxonase 1 gene
(PON1) (combined allele p=8610
24). The best model was the TT genotype relative to the CC/CT genotypes, and resulted in
an OR of 1.32 (95% CI=1.13–1.53, p=4610
24).
Conclusions: These studies identify single locus associations with preterm birth for both maternal and fetal genotypes in
two populations of European ancestry.
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Introduction
Preterm birth (PTB) (,37 weeks of gestation) is a major
obstetrical problem, contributing to a substantial proportion of
infant morbidity and mortality worldwide. Preterm birth accounts
for as much as 75% of perinatal mortality and a disproportionately
large percentage of infant morbidities [1–4]. In the US alone, of
the approximately five million births each year almost 13% are
born preterm, accounting for greater than $26 billion per year in
excess health care costs [5,6]. The majority of PTB (,75%) results
from spontaneous contractions often associated with infection,
prelabor preterm rupture of the membranes and unknown causes
[7]. Based on human and animal studies, four main pathways have
been hypothesized to lead to PTB: 1) activation of maternal or
fetal hypothalamic pituitary-adrenal axis, 2) inflammation and
infection, 3) decidual hemorrhage, and 4) uterine distension [8].
These pathways converge on a final terminal pathway where
uterotonins, such as prostaglandins and extra cellular matrix
(ECM) degrading proteases, are released leading to early
contractions, cervical ripening and rupture of the membranes
eventually resulting in PTB. The specific factors involved in these
putative PTB pathways and how each contributes to the etiology
of PTB are poorly understood.
There is growing evidence that among the risk factors that have
been hypothesized to be associated with PTB genetic predisposi-
tion plays a significant role. First, personal and family history of
PTB are among the strongest known risk factors for PTB [9–11].
Second, twin studies estimate the heritability of PTB at 20–40%
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geographic ancestry is associated with risk for PTB; therefore, it is
reasonable to conclude that genetic variations can affect risk
[14–16]. Finally, in the last ten years many studies have found
significant genetic associations with PTB, particularly with genes
in the inflammation and infection pathway [17–19]. However,
often these findings fail to replicate [20].
Recently, a candidate gene association study of PTB was
performed examining 1,536 single nucleotide polymorphisms
(SNPs) in approximately 130 candidate genes [21]. The strongest
maternal associations with PTB were in factor V (FV), factor VII
(FVII) and tissue plasminogen activator (tPA) in European
Americans (EA). These genes are involved in the complement-
coagulation pathway, related to decidual hemorrhage. The most
significant fetal associations were in interleukin 10 receptor
antagonist (IL-10RA) and other genes related to the infection
and inflammation pathway.
In the present study we sought to identify genetic risk factors for
PTB in a Norwegian cohort, and corroborate these results with
data from the study described above[21]. In addition to the SNPs
that were previously studied we included 132 SNPs from 14 genes
emphasizing genes from the complement coagulation pathway
that were not previously represented because of strong associations
between SNPs in this pathway and PTB previously identified in
EA. The results of the two studies were compared to identify genes
involved in PTB pathways.
Results
Demographic and Clinical Characteristics
Clinical differences between cases and controls for the
Norwegian Mother and Child Cohort (MoBa) are presented in
Table 1. There were no statistically significant differences between
cases and controls for APGAR score at either 1 minute or 5
minutes, maternal age or smoking; however, as expected, cases
had babies with lower birth weight and gestational age (p,0.001
for both). Additionally, cases and controls significantly differed in
parity (p,0.001), where having one or more children was
protective against PTB (OR=0.45, CI=0.30–0.67, p-value,
0.001).
The MoBa and the Centennial Medical Center study (Cenn)
used slightly different but substantially overlapping gestational age
definition; in MoBa ,36
6/7 weeks was used and in the Cenn study
cases were defined by a gestational age of ,36
0/7 weeks (Table 2).
The controls were defined by a gestational age of $39
0/7 weeks in
the Moba study and $37
0/7 weeks in the Cenn study. Gravidity,
gestational age and birth weight differed between the two study
populations in cases and controls. When data from the two studies
are combined, the median gestational age was 248 days
(range=166–258) in cases and 278 days in controls
(range=257–296).
Single Locus Association
Of the 1430 SNPs analyzed in MoBa, there were 125 suggestive
(p,0.05) allelic and/or genotypic single locus results in maternal
samples and 142 suggestive allelic and/or genotypic results in fetal
samples (Figure 1A-D, Table S3). The most significant maternal
single locus result was in collagen, type 1, alpha 2 (COL1A2) at
rs2472 (allelic p=2610
23, genotypic p=1610
23) (Table 3). This
SNP was also associated in fetal samples (allelic p=8610
23,
genotypic p=8610
23) (Table 3). In maternal samples this SNP had
an OR of 0.32 (95% CI=0.16–0.66, p=2610
23) when comparing
the AG genotype to the AA genotype. This result remained
significant after adjusting for parity (p=2610
23), and was also
identified using the method PRAT (Table 3). In addition to rs2472,
nine SNPs of the thirty-four examined in COL1A2 associated with
PTB (p,0.05); seven SNPs associated in fetal samples only, one in
maternal samples only and one in both maternal and fetal samples
(Table 3). None of these results were significant after correction for
multiple testing with FDR (q=0.20).
The most significant fetal single locus result was in tissue factor
pathway inhibitor (TFPI) at rs6434222 (allelic p=6610
25,
genotypic p=1610
24, both of which were significant after FDR
correction) (Table 3). This SNP was not significantly associated
with PTB in maternal samples. In fetal samples this SNP had an
OR of 2.49 (95% CI=1.59–3.91, p=7610
25) for the additive
model, that remained significant after adjusting for parity
(p=8610
25). In addition to rs6434222 eight SNPs out of the
seventeen examined in TFPI associated in both maternal and fetal
samples. All of the associating SNPs in TFPI were also significant,
using PRAT (Table 3). Only rs6434222 was significant after FDR
correction.
Several significant haplotype associations, mostly spanning two
areas ofthe TFPI gene,were identified(Figure2).One areaincludes
five SNPs denoted by Block 1 (rs12693471, rs8176541, rs7586970,
rs3213739 and rs8176508). All of these SNPs had suggestive
associations in the single SNP analyses, and showed evidence of
both maternal and fetal haplotype association. The other significant
haplotype effects were in fetal samples and appear to be driven by
rs6434222. Maternal single locus and haplotype associations were
not observed for this SNP. In maternal and fetal controls there was
weak linkage disequilibrium (LD) between the two regions of the
genes defined by Block 1 and rs6434222, indicating two potentially
independent effects within this gene (Figure S1).
Corroboration of Results
SNPs were included for combined analysis if the allele or
genotype p-values were less than 0.05 in one study (MoBa or
Cenn) and less than 0.20 in the other study. In maternal samples,
60 SNPs met the criterion for the combined analysis, 30 of which
had significant allelic and/or genotypic p-values in the combined
dataset after correction for multiple testing with FDR (Table S4).
The most significant single locus result in maternal combined
samples was in prostaglandin E receptor 3 (PTGER3) (Table 4).
There were six SNPs in this gene that met the criteria for
combined analysis and three of these (rs2072947, rs977214 and
rs6665776) had significant allelic and/or genotypic results in the
combined data, all of which were significant after correction with
Table 1. Clinical characteristics.
Variable
1Cases (n=207) Controls (n=217)
2p
Parity 0 [0–4] 1 [0–4] ,0.001
Gestational Age (days) 253 [182–258] 280 [273–286] ,0.001
Birth weight (grams) 2810 [950–4000] 3650 [2610–4970] ,0.001
APGAR at 1 minute (%,7) 16 (8%) 12 (6%) 0.355
APGAR at 5 minutes (%,7) 3 (1%) 5 (2%) 0.522
Maternal Age (yrs) 29 [20–34] 30 [21–34] 0.203
Smoking (%) 22 (12%) 21 (11%) 0.770
Parity is defined as the number of times a woman has given birth.
Medians are reported with the range in brackets.
1Cases are defined as ,37 weeks gestation compared with the women
delivering at term between 39–40 weeks (controls).
2P-values are calculated by Mann Whitney U- test for continuous variables and
chi-square test or Fisher’s exact test for dichotomous variables.
doi:10.1371/journal.pone.0009040.t001
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correction. Two of these SNPs (rs977214 and rs6665776) strongly
associated with PTB in the combined data (rs977214: genotypic
p=3 610
24; rs6665776: genotypic p=5610
24) (Table 4). The
best model for rs977214 after correcting for study site and
gravidity was the AG/GG genotypes relative to the AA genotype
and resulted in an OR of 0.55 (95% CI=0.37–0.82, p=3610
23),
indicating a protective effect (Table 5). This SNP deviated from
HWE in both cases and controls in the combined data set;
however, the sign of the inbreeding coefficients (f) was negative in
controls (20.097) and positive in cases (0.130), indicating that the
deviations from HWE were not due to genotyping error as cases
and controls were randomly placed on each plate for genotyping,
nor are these results due to mixing of population samples
(Wahlund Effect). The best model for rs6665776 after correcting
for study site and gravidity was CC genotype relative to the AA/
AC genotypes and had an OR of 1.75 (95% CI=1.18–2.60,
p=5 610
23) (Table 5). There was strong LD (r
2$0.95) between
these two SNPs in both Cenn and MoBa maternal controls
(Figures S2A and B). Haplotype associations spanned three general
regions of the PTGER3 gene; two of these regions were significant
only in the Cenn study and one of these regions was significant
only in the Moba study (Figure 3A, Table S5); however, taken
together they both support the association of this gene with PTB.
In fetal samples, 44 SNPs met the criteria for the combined
analysis, 28 of these SNPs had significant allelic and/or genotypic
associations in the combined data after correction for multiple
testing with FDR (Table S4). The most significant single locus
association in pooled samples was in PON1 at rs854552 (allelic
p=8 610
24, genotypic p=2610
23). This SNP remained signifi-
cant after correction for multiple testing with FDR. The best
model after correcting for study site and gravidity compared the
rs854552 TT genotype to the CC/CT genotypes and resulted in
an OR of 1.32 (95% CI=1.13–1.53, p=4610
24) (Table 5). The
LD patterns were similar in Cenn and MoBa fetal controls (Figure
S2C and D). There were very few haplotype or single locus
associations in the Cenn study for PON1; however, there were
strong haplotype associations in the MoBa data that is being
driven by the single locus association at rs854552 (Figure 3B,
Table S5).
Discussion
Our study explored candidate genes in the four hypothesized
preterm labor pathways [8] for associations with PTB and
determined the effect size of associations that corroborated a
second PTB cohort. In MoBa the only association significant after
correction for multiple testing was in fetal samples at rs6434222 in
TFPI. This SNP was not significantly associated with PTB in
maternal samples and there was only weak LD in maternal
controls with this SNP, whereas in fetal controls there was stronger
LD between this SNP and other SNPs with significant associations
(Figure S1). This indicates that this SNP may exhibit an
independent fetal single locus association with PTB. This
conclusion is supported by the strong fetal haplotype associations
involving this SNP in fetal but not maternal samples. TFPI is
involved in the complement coagulation pathway and inhibits
Coagulation Factor 3 and Coagulation Factor 10, both of which
are important for the production of Coagulation Factor 2 (F2), a
critical component in clot formation. Overproduction of F2 can
cause contractions and activate matrix metalloproteinases (MMPs)
[22–24], possibly leading to degradation of the extracellular matrix
(ECM). ECM degradation causes changes in the cervix and
rupture of the membranes that may result in PTB. The single SNP
associations may indicate TFPI as a novel candidate gene for PTB
risk. While these associations did not corroborate in the Cenn
population other genes in the complement coagulation pathway,
particularly tPA were associated with PTB in previous reports,
indicating that this pathway may be important in PTB [21].
Among the genes examined for association with PTB ,19% (26
genes) had suggestive associations (p,0.05) in fetal but not in
maternal samples. This may indicate a potential paternal genetic
effect, at least in part, for some pathways involved in PTB. This is in
contrast to recent studies, based on epidemiological data, indicating
that paternal factors contribute little to the risk of PTB [25,26].
However, to adequately understand the involvement of the
Table 2. Comparisons of clinical variables between MoBa and Cenn.
Population Variable MoBa (n=217) Cenn (n=199)
1p
Controls Gravidity 1 [0–7] 2 [1–8] ,0.0001
Gestational Age (days) 280 [273–286] 274 [257–296] ,0.0001
Birthweight (grams) 3650 [2610–4970] 3446 [2100–4661] ,0.0001
APGAR at 1 minute (% ,7) 12 (6%) 4 (2%) 0.081
APGAR at 5 minutes (% ,7) 5 (2%) 0 (0%) 0.037
Maternal Age (yrs) 30 [21–34] 28 [16–43] 0.045
Smoking (%) 21 (11%) 28 (15%) 0.284
Cases Gravidity 0 [0–5] 2 [1–9] ,0.0001
Gestational Age (days) 253 [182–258] 239 [166–255] ,0.0001
Birthweight (grams) 2810 [950–4000] 2150 [370–3790] ,0.0001
APGAR at 1 minute (% ,7) 16 (8%) 42 (25%) ,0.001
APGAR at 5 minutes (% ,7) 3 (1%) 10 (6%) 0.018
Maternal Age (yrs) 29 [20–34] 27 [17–40] 0.065
Smoking (%) 22 (12%) 54 (32%) ,0.001
Gravidity is defined as the number of times a woman has been pregnant.
Medians are reported with the range in brackets.
1P-values are calculated by Mann Whitney U- test for continuous variables and chi-square test for dichotomous variables.
doi:10.1371/journal.pone.0009040.t002
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examine either maternal and fetal samples simultaneously or trios
consisting of paternal, maternal and fetal samples are needed. As
better methods are developed to handle such analyses, particularly
with respect to perinatal medicine, where both maternal and fetal
genomes are involved in the disease outcome, this question can be
explored in greater detail. While in general, the geneticcontribution
of paternal genes may be marginal, it is possible that particular
pathways are influenced more by paternal genetic contributions.
The genes that were suggestive for association with PTB in fetal
(IL1A, IL4 and MMP8) and maternal samples (IL-1R2 and IL-6R)
in both the MoBa and Cenn studies were mainly infection and
inflammation genes (Figure 4, sector D). It is interesting to note that
most associating fetal variants were in the cytokines genes
themselveswhereasmaternalassociationsweregenerallyincytokine
receptor genes (Figure 4, sector H). This suggests maternal
polymorphisms may influence or modulate functional contributions
of fetal SNPs in the inflammatory pathways. We speculate that fetal
immunological response to the maternal environment may be
affected by maternal variants, thereby regulating the impact of fetal
encoded risks through complex interactions. Further studies,
particularly genome-wide association studies and inclusion of
paternal samples will be essential for elucidating the relative
contributions of paternal and fetal genotypes to the risk of PTB.
In our study several genes from multiple biological pathways had
modest to strong associations with PTB, and many of these
corroborated an independent data set on PTB. While this study did
not directly test replication, results from the combined analyses
indicate genes with universal or generalized associations. The most
significant associations in the combined samples were from two major
PTB pathways: 1) prostaglandin (PG) effectors (PTGER3) in maternal
samples that influence PG mediated uterotonic activity and 2)
decidual hemorrhage (PON1) in fetal samples. PTGER3 is a receptor
required for prostaglandin response that plays a role in initiation of
contraction (labor). Activation of the inflammatory process has been
documented to increase prostaglandins[27,28]. Several SNPs in
PTGER3 were significant in the combined MoBa and Cenn
maternal samples, supporting the role of variation in this contractile
agent in the final effecter pathway and PTB. However, we note that
the patterns of haplotype association in MoBa and Cenn differed.
Although there is some evidence for differences in LD pattern
between these two cohorts, we do not think that the differences are
enough to motivate such strong differences in haplotype associations,
especially since there is some evidence for SNPs associating in both
studies in the middle portion of the gene. Rather it is possible that our
data support allelic heterogeneity across the two studies.
The second pathway that associated with PTB in the two cohorts
is the decidual hemorrhage pathway that can potentially activate
Figure 1. Single locus association results in MoBa study. Each point on the graph represents an association test either allelic (a, c) or
genotypic (b, d). The x axis is SNP position in chromosomal order and the y axis is the inverse negative log of the p-value. Suggestive associations are
highlighted in genes with at least one association at p,0.005. TFPI (rs6434222) is significant after correction for multiple testing with FDR. Maternal
samples are represented in panels a and b, and fetal samples are represented in panels c and d.
doi:10.1371/journal.pone.0009040.g001
Genetics of Preterm Birth
PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9040biochemical mediators such as matrix metalloproteinases and cause
ECM degradation. PON1 is a member of the paraoxonase gene
family and it can impact preterm labor in multiple ways. Primarily,
mutations in this gene are associated with changes in lipid profiles
(high-density lipoprotein (HDL) low-density lipoprotein (LDL))
[29,30]. HDL increases the production of prostaglandin E2,l e a d i n g
to contractions [31]. Additionally, hypothesized mutations in this
gene could indirectly disrupt thrombotic pathways and activation of
thrombin and plasminogen cascade can activate MMPs and MMP
mediated ECM degradation [31–33]. A previous study examining
one mutation in PON1 (rs662) found an association in fetal but not
maternalChinesesamples[31].WhilethisSNPwasnotassociatedin
the Cenn, MoBa or pooled samples we did identify a different SNP
(rs854552) located in the 3’UTR of the gene that was strongly
associated with PTB in the pooled fetal samples. It is difficult to
conclude that this SNP replicates the association found in the
Chinese samples; however, this gene does replicate in two
populations of European descent and the Chinese population,
indicating perhaps allelic heterogeneity for PON1, but more
importantly a consistent role for PON1 in PTB.
Our studies were limited in that they are candidate gene studies;
therefore many associations may be missed, including genes
representing novel biology with respect to PTB. In addition, the
case-control criteria for the MoBa and Cenn studies were slightly
different and while there were still many associations discovered,
studies with more carefully defined phenotypic criteria are needed
to validate these results. Finally, we emphasize that although some
results were found to be consistent across MoBa and Cenn, there
was evidence for different patterns of association. This was
especially pronounced for TFPI, which did not corroborate, and
PTGER3 haplotype analyses that showed differences in genic
region that associated with PTB. This may be due to underlying
population differences between our samples, possibly allele
frequency differences that impact power. Alternatively, there
could be population specific risk alleles that were indirectly
detected through our analyses. Lastly, it is possible that the
underlying genetic models for PTB are multi-factorial and that the
ability to detect single locus association is impacted by changes in a
second or third factor that were not corrected measured or
corrected for in our analyses [34].
Table 3. Significant single locus maternal and fetal associations.
Gene SNP Genic Role Sample Allele
Case
MAF
Control
MAF Allele p Genotype p PRAT Case
PRAT
Control
COL1A2 rs388625 Intron Fetal A 0.37 0.46 0.01 0.01 8610
23 0.05
rs411717 Intron Fetal A 0.37 0.46 0.01 0.01 8610
23 0.05
rs420257 Intron Fetal G 0.24 0.34 1610
23 1610
23 2610
23 0.03
rs389328 Intron(boundary) Fetal T 0.12 0.19 0.01 0.01 0.02 0.12
rs42524 Coding exon Fetal G 0.19 0.26 0.01 0.02 0.02 0.32
rs2521205 Intron Maternal C 0.43 0.51 0.02 0.05 0.03 0.654
Fetal C 0.45 0.52 0.04 0.13 0.06 0.83
rs42528 Intron Fetal A 0.20 0.28 8610
23 0.02 0.01 0.54
rs2472 Intron Maternal G 0.03 0.07 2610
23 1610
23 0.02 ,1610
23
Fetal G 0.03 0.08 8610
23 8610
23 0.04 2610
23
rs441051 Intron Fetal A 0.17 0.25 3610
23 0.01 4610
23 0.59
rs7804898 Intron Maternal G
10.17 0.14 0.21 0.02 0.04 0.05
TFPI rs12693471 Downstream Maternal G 0.27 0.35 9610
23 0.01 0.01 0.84
Fetal G 0.26 0.36 4610
23 0.01 4610
23 0.68
rs8176541 Intron Maternal A 0.27 0.35 8610
23 0.01 0.01 0.78
Fetal A 0.26 0.36 4610
23 0.01 4610
23 0.66
rs7586970 Intron Maternal G 0.27 0.35 8610
23 0.01 0.01 0.78
Fetal G 0.26 0.36 4610
23 0.01 4610
23 0.65
rs3213739 Intron Maternal A
10.38 0.46 0.03 2610
23 9610
23 0.12
Fetal A 0.38 0.48 4610
23 0.01 1610
23 0.69
rs8176508 Intron Maternal A 0.41 0.36 0.16 0.05 0.09 0.03
Fetal A 0.41 0.32 4610
23 0.01 2610
23 0.31
rs2041778 Intron Maternal G 0.33 0.40 0.04 0.06 0.09 0.03
Fetal G 0.32 0.39 0.03 0.08 0.03 0.59
rs3755248 Intron Maternal G 0.27 0.35 7610
23 0.02 0.01 0.84
Fetal G 0.28 0.34 0.03 0.09 0.05 0.81
rs7573488 Intron Maternal G
10.24 0.31 0.01 0.01 9610
23 0.72
Fetal G 0.23 0.31 0.02 0.06 0.03 0.37
rs6434222 Intron Fetal T 0.17 0.08 6610
25*1 610
24* ,1610
23 0.63
*Significant after correction for multiple testing with FDR (q=0.2).
1Cases deviated from HWE in maternal samples at rs3213739 (p=0.01), rs7573488 (p=0.04), rs7804898 (p=0.05).
doi:10.1371/journal.pone.0009040.t003
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genes with significant or marginally significant associations with
PTB in two separate samples. When samples were combined,
multiple SNPs with strong allelic or genotypic p-values were
identified, including SNPs involved in inflammation and infection,
ECM degradation and decidual hemorrhage pathways. This study
validated a previously identified genetic association with PTB and
further studies can address the biological role these genes play.
Materials and Methods
Subjects
The Norwegian Mother and Child Cohort (MoBa) is a national
pregnancy cohort designed to explore the causes of complex
pregnancy related phenotypes. The main objective of this cohort is
to develop a long term resource to test hypotheses relating to
pregnancy outcomes and childhood health. More than 100,000
pregnancies have been included during the study period of 1999–
2008 by the Norwegian Institute of Public Health. The target
population consisted of all pregnant women in Norway. Women
were invited to participate during their routine ultrasound scan at
gestational week 17–18. All hospitals and maternity units with
more than 100 deliveries annually were invited to participate, and
50 of 52 such units participated. The total participation rate was
42.7% [35]. Epidemiological data and biological material have
been and will continue to be collected from both the mothers and
the children. The MoBa study collected data on nutrition, overall
health status, and child outcome. In addition to these variables
additional data were added from the Medical Birth Registry of
Norway. The MoBa study has been described in detail elsewhere
[35]. The present study used samples derived from a subset of the
MoBa cohort (version 2) available at its outset (53,711 pregnancies)
[36].
Data from the Medical Birth Registry on gestational age, type of
delivery, intrauterine fetal death, congenital malformations and
plurality were used. Gestational age was based on ultrasound in
Figure 2. Maternal and fetal single locus and haplotype associations for TFPI. Asterisks to the right of a SNP indicates significant single
locus allelic associations with PTB, red indicates significance in maternal samples and black indicates significance in fetal samples. The number of
asterisks denotes the strength of significance. Lines denote a significant haplotype, red is for maternal samples and black is in fetal samples. The
thickness of the line denotes the strength of significance. Only SNPs with MAF . 0.05 in maternal or fetal samples are presented in graph. Linkage
disequilibrium plots (r
2) are shown for fetal controls.
doi:10.1371/journal.pone.0009040.g002
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menstrual period. However, ultrasound was the main method of
determining gestational age as most pregnancies in Norway are
dated by ultrasound.
The cases in this study were defined as singletons with
spontaneous onset of PTB between 22 gestational weeks and 0
out of 7 days (22
0/7) and 36
6/7 gestational weeks in women aged
20–35 years. This age range was chosen to ensure that women at
high risk for PTB because of age (young women less than 20 years
of age and older women greater than 35 years of age) were not
included in the study. Type of delivery was recorded as
spontaneous labor, induced labor, or pre-labor caesarean section.
Women with induced labor and pre-labor caesarean section
groups, intrauterine fetal death, plurality and if the fetus had
congenital malformations were all excluded. The definitions of
these conditions have been previously described [7]. Other
exclusion criteria were pre-existing medical conditions such as
diabetes, hypertension, autoimmune diseases, inflammatory bowel
diseases, systemic lupus erythematosus, rheumatoid arthritis,
scleroderma or any immune-compromised condition. Women
were also excluded if they had pregnancy complications such as
preeclampsia, hypertension, diabetes, small for gestational age
(according to intrauterine growth curves), abruption of the
placenta, placenta previa, cervical cerclage or fetal malformations
[37]. The controls were selected according to the same criteria as
above except for spontaneous onset of term birth with gestational
age between 39
0/7 and 40
6/7 weeks. The Regional Committee for
Medical Research and Ethics (S-06075) approved the MoBa study
and approval was also achieved from the Norwegian Data
Inspectorate.
For this study 434 mother-baby pairs (214 cases and 220
controls) were selected for analysis from MoBa. A previously
published study on PTB was used to corroborate results from our
study. This study utilized samples from the Centennial study
(Cenn) collected in Nashville, TN and is described in detail
elsewhere [21]. This sample consisted of maternal and fetal
individuals of both European (European American – EA) and
African (African-American) descent, but only the EA samples were
used for corroboration. The combined datasets contained 764
maternal samples (353 cases and 411 controls) and 738 fetal
samples (343 cases and 395 controls).
DNA Genotyping and Quality Control
A total of 1,536 tag SNPs were selected from 143 PTB
candidate genes. Of these 1,404 SNPs from 129 genes were chosen
because they had been included in a previous study of PTB [21].
In addition, 132 SNPs from 14 genes in the complement-
coagulation pathway were added to the present study because
this pathway was associated with PTB previously. SNPs in Velez et
al[21] were selected based on their ability to tag surrounding
variants in the Caucasian and Yoruban populations of the
HapMap database (http://www.hapmap.org). A minor allele
frequency of 0.07 in CEPH and 0.20 in YRI and an r
2 of 0.80
was used to determine tagSNPs. The additional SNPs were
selected as tagSNPs in the CEPH, based on similar criteria.
Genotyping was performed on the Illumina GoldenGate Assay
system. 1,430 SNPs encompassing 140 candidate genes were
successfully genotyped with genotyping efficiency greater than
95% (Table S1).
Table 4. Genetic associations in combined MoBa and Cenn samples.
Sample Gene SNP Allele
Cenn
Case
Allele
Freq
Cenn
Cont
Allele
Freq
Cenn
Allele
p
Cenn
Genotype
p
MoBa
Case
Allele
Freq
MoBa
Cont
Allele
Freq
MoBa
Allele
p
MoBa
Genotype
p
Pooled
Case
Allele
Freq
Pooled
Cont
Allele
Freq
Pooled
Allele p
Pooled
Genotype
p
Maternal PTGER3 rs977214 G 0.09 0.13 0.17 5610
23 0.06 0.09 0.06 0.04 0.07
1 0.11
2 0.02* 3610
24**
rs6665776 A 0.09 0.12 0.24 0.01 0.06 0.09 0.06 0.04 0.07
1 0.11 0.02* 5610
24*
rs2072947 C 0.53 0.44 0.02 0.03 0.41 0.46 0.21 0.03 0.46 0.45 0.58* 0.04*
Fetal PON1 rs854552 C 0.22 0.28 0.12 0.25 0.21 0.30 2610
23 6610
23 0.21 0.29 8610
24*2 610
23*
rs2272365 G 0.19 0.13 0.05 0.05 0.17 0.12 0.04 0.12 0.18 0.13 5610
23* 0.01*
1cases deviated from HWE at rs977214 (p=0.02), rs6665776 (p=0.02).
2controls deviated from HWE at rs977214 (p=0.05).
*Significant after correction for multiple testing with FDR (q=0.2).
**Significant after correction for multiple testing with Bonferroni.
doi:10.1371/journal.pone.0009040.t004
Table 5. Odds ratios for significant associations in pooled samples.
Sample Gene SNP Genic Location Model OR 95% CI Model p
Maternal PTGER3 rs977214 Intron AAvsAG/GG 0.55 0.37–0.82 3610
23
rs6665776 Intron AA/ACvsCC 1.75 1.18–2.60 5610
23
rs2072947 Intron CCvsCT/TT 0.68 0.47–0.97 0.03
Fetal PON1 rs854552 39UTR CC/CTvsTT 1.32 1.13–1.53 4610
24
rs2272365 Intron GG/GTvsTT 0.61 0.44–0.85 9610
24
Logistic regression models adjusted for center of collection and gravidity. Center of collection was not significant for any of the models (p.0.1), gravidity was significant
for all of the models (p,5610
23).
doi:10.1371/journal.pone.0009040.t005
Genetics of Preterm Birth
PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9040Both maternal and fetal samples were excluded if the last
menstrual period and birth weight were not consistent with case-
control status, suggestive of sample misidentification or if extracted
DNA was not available in the Biobank. Additionally, samples were
excluded if greater than 1% of the SNPs had Mendelian errors.
This was done to ensure high quality genotyping accuracy.
Additionally, individuals were excluded for low genotyping
efficiency (,95%). The final sample size included 419 fetal
samples (203 cases, 216 controls) and 424 maternal samples (207
cases, 217 controls).
DNA Genotyping: Corroboration of Results
A total of 1,316 SNPs in the present study overlapped with the
previous study on PTB in EA maternal and fetal samples (Table
S1). Additionally, 38 SNPs from three genes (plasminogen [PLG],
methionine synthase reductase [MTRR] and tissue factor pathway
inhibitor [TFPI]) were successfully genotyped (genotyping effi-
ciency .95%) in the Cenn samples, using the Sequenom platform.
A total of 304 maternal and 272 fetal samples were successfully
genotyped on this platform with .85% genotyping efficiency.
These genes were not originally included in the Cenn analysis;
however, significant associations were identified in the MoBa
samples and the Cenn samples were reanalyzed for association
with these SNPs to determine if these associations could be
replicated (Table S2). Institutional Review Boards at TriStar
Nashville, TN and Vanderbilt University, Nashville, TN approved
this study.
Statistical Analysis: MoBa
Chi-square tests were used to examine differences between cases
and controls for APGAR at 1 minute (,7 versus $7), APGAR
score at 5 minutes (,7 versus $7) and smoking (non-smokers
versus smokers). Parity (number of times a woman has given birth
defined by birth registry), gestational age (days), birth weight
(grams) and maternal age were tested for normality using Shapiro-
Wilks tests. None of these variables were normally distributed;
therefore, these variables were analyzed with nonparametric
Mann-Whitney two-sample ranksum tests. Stata version 10
Figure 4. Identification of genes associated with PTB in
multiple populations. Genetic associations are defined as any
suggestive allelic or genotypic association (p,0.05) occurring in a
given gene. These associations are uncorrected for multiple testing and
are before correction for covariates such as parity. A: ADRB2, CARD15,
CBS, CCL8, EPHX1, FAS, GSTP1, IL1B, IL1RN, IL2RB, IL8RA, MMP2, NFKBIE,
PAFAH1B1, PGRMC2, PTGES B: ADH1B, MTHFR, NFKB1, PTGFR, SLC6A4,
TLR4 C: CRH, F5, HSD11B1, HSD17B7, HSPA1A, IGFBP3, IL10RB, IL13,
IL15, PGEA1, PGRMC1, PTGER2, SERPINE1, TCN2, TIMP4 D: HSPA6, IL1A,
IL4, MMP8 E: CBS, GSTP1, HSPA14, IGF1, IL1B, IL1RN, IL2RB, NFKBIA,
NFKBIE, NOS3, PAFAH1B1, PTGS2, SLC23A1 F: IL10RA, IL5, MMP1, MMP3
G: CCL2, CTLA4, DHFR, F5, IL10, PGRMC1, PTGS1, TLR2, TLR7, TNFRI,
TNFRII, VEGF H: COL1A1, F7, IL18, IL1R2, IL6R, MTHFD1, NAT1, PLA2G4A
I: COL5A1, IL1R1, IL4R J: KL, PLAT K: COL1A2, COL3A1, CYP19A1,
IL1RAP, IL2RA, NFKBIB, PON2, PTGER3, TIMP3, TSHR, UGT1A1 L: CRHR2,
EDN2, NR3C1, PGR, PON1, TREM1 M: COL5A2, CRHBP, EPHX2.
doi:10.1371/journal.pone.0009040.g004
Figure 3. Significant single locus and haplotype associations in MoBa and Cenntennial studies. a) PTGER3 for maternal samples and b)
PON1 for fetalsamples.Asteriskstotherightofasingle nucleotidepolymorphismindicates significantsinglelocus allelic associationswithpretermbirth,
bluedenotessignificanceinpooledsamples,redindicatessignificanceintheMoBastudyonlyandblackindicates significanceintheCennstudyonly.All
pooled results are significant after correction for multiple testing with FDR. The number of asterisks denotes the strength of significance. Lines denote a
significant haplotype, red is for the MoBa study and black is for the Cenntennial study. The thickness of the line denotes the strength of significance.
Linkage disequilibrium plots (r
2) are shown for MoBa maternal controls for PTGER3 (a) and MoBa fetal controls for PON1 (b).
doi:10.1371/journal.pone.0009040.g003
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Station, TX).
Gene names, marker positions (base pair – bp) and marker
function were identified using the SNPper database (http://
snpper.chip.org). Allele and genotype differences between cases
and controls, deviations in Hardy-Weinberg equilibrium (HWE)
and inbreeding coefficients (f) were calculated with PLINK
(http://pngu.mgh.harvard.edu/purcell/plink/)[38], the Whole-
genome Association Study Pipeline (WASP) developed at the
Center for Human Genetics Research of Vanderbilt University
(http://chgr.mc.vanderbilt.edu/wasp/) and Powermarker soft-
ware programs [39]. Statistical significance for these analyses
was determined using chi-square tests or Fisher’s exact tests (if
there were less than five individuals for any allele or genotype).
These results were corroborated using a prevalence based
association test (PRAT) [40]. This test calculates a global allele
frequency based on the prevalence of the disease in order to
calculate expected frequencies of each genotype in cases and
controls separately, and a permutation test is used to determine the
significance. The global allele frequency was determined using a
PTB prevalence of 5% in the Norwegian cohort. False discovery
rate (q=0.2) was used to correct for multiple testing in maternal
and fetal samples, separately [41].
The most significant allelic and/or genotypic associations were
followed up with additive, dominant and recessive genotype
models, using the minor allele as the risk allele, using logistic
regression. Significant (p,0.05) logistic regression models were
adjusted for parity because this was the only risk factor that was
significantly different between cases and controls in MoBa. These
analyses were performed with Stata version 10. Graphical
representation of significant results and haplotypes was performed
with Haploview [42].
Statistical Analysis: Corroboration of Results
The MoBa and Cenn samples were combined for SNPs that
met the criteria described below, and analyzed for allelic and
genotypic association. SNPs were included for combined analysis if
the allele or genotype p-values were less than 0.05 in one study
(MoBa or Cenn) and less than 0.20 in the other study. This
criterion, while arbitrary, was designed to capture associations that
may have been missed due to inadequate power in an individual
study. However, this criterion was also designed to exclude
associations that were primarily driven by only one of the two
studies. Genotype and allele associations were corrected for
multiple testing in maternal and fetal sample separately with
FDR (q=0.2). An effect size was determined with logistic
regression for additive, recessive and dominant models again,
using the minor allele as the risk allele and correcting for site of
collection and gravidity.
The genes with the most significant single SNP associations in
maternal and fetal samples were followed-up with 2, 3 and 4
marker sliding window haplotype analysis using Unphased [43].
This software uses a quasi-Newton algorithm to maximize the
likelihood of each haplotype when an individual’s phase is
unknown. The overall test of association is a likelihood ratio test
based on the null hypothesis that all of the haplotypes have equal
odds ratios. Haplotype analysis was performed in the MoBa and
Cenn samples separately.
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Figure S1 Linkage disequilibrium plots (r2) are shown for
maternal (a) and fetal (b) controls for TFPI.
Found at: doi:10.1371/journal.pone.0009040.s001 (0.48 MB TIF)
Figure S2 Linkage disequilibrium plots (r2) are shown for a)
Cenn maternal PTGER3 b) Moba maternal PTGER3 c) Cenn
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Found at: doi:10.1371/journal.pone.0009040.s002 (1.00 MB TIF)
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